EMA: Draft GL for OIPs [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2024-04-19 17:40 (58 d 11:58 ago) – Posting: # 23959
Views: 1,459

Dear all,

as a birthday gift the EMA published a

Draft guideline on the requirements for demonstrating therapeutic equivalence between orraly inhaled products (OIP) for asthma and chronic obstructive pulmonary disease (COPD).

Consultation is open until 30 October 2024.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,057 posts in 4,840 threads, 1,641 registered users;
138 visitors (0 registered, 138 guests [including 87 identified bots]).
Forum time: 05:39 CEST (Europe/Vienna)

If you tell the truth you don’t have to remember anything.    Mark Twain

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5